AAAAAA

   
Results: 1-13 |
Results: 13
CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY
Authors: LUNDIN J OSTERBORG A BRITTINGER G CROWTHER D DOMBRET H ENGERT A EPENETOS A GISSELBRECHT C HUHN D JAEGER U THOMAS J MARCUS R NISSEN N POYNTON C RANKIN E STAHEL R UPPENKAMP M WILLEMZE R MELLSTEDT H
Citation: J. Lundin et al., CAMPATH-1H MONOCLONAL-ANTIBODY IN THERAPY FOR PREVIOUSLY TREATED LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II MULTICENTER STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3257-3263
5TH IASLC LUNG-TUMOR BIOLOGY WORKSHOP, AUGUST 13-17, 1996, ERMATINGEN, SWITZERLAND
Authors: BUNN P CARBONE D GRIM J HARRIS C HAVEMANN K MABRY M ROTH J SAIJO N POULSEN HS STAHEL R TAKAHASHI T TWENTYMAN P
Citation: P. Bunn et al., 5TH IASLC LUNG-TUMOR BIOLOGY WORKSHOP, AUGUST 13-17, 1996, ERMATINGEN, SWITZERLAND, Annals of oncology, 8(1), 1997, pp. 27-36
PRETREATMENT MINIMAL STAGING AND PROGNOSTIC FACTORS FOR NONSMALL CELLLUNG-CANCER
Authors: FELD R ABRATT R GRAZIANO S JASSEM J LACQUET L NINANE V PAESMANS M ROCMANS P SCHIEPERS C STAHEL R STEPHENS R
Citation: R. Feld et al., PRETREATMENT MINIMAL STAGING AND PROGNOSTIC FACTORS FOR NONSMALL CELLLUNG-CANCER, Lung cancer, 17, 1997, pp. 3-10
5TH IASLC LUNG-TUMOR BIOLOGY WORKSHOP, AUGUST 13-17, 1996, ERMATINGEN, SWITZERLAND
Authors: BUNN P CARBONE D GRIM J HARRIS C HAVEMANN K MABRY M ROTH J SAIJO N POULSEN HS STAHEL R TAKAHASHI T
Citation: P. Bunn et al., 5TH IASLC LUNG-TUMOR BIOLOGY WORKSHOP, AUGUST 13-17, 1996, ERMATINGEN, SWITZERLAND, Lung cancer, 16(2-3), 1997, pp. 239-257
CD24, A MUCIN-TYPE GLYCOPROTEIN, IS A LIGAND FOR P-SELECTIN ON HUMAN TUMOR-CELLS
Authors: AIGNER S STHOEGER ZM FOGEL M WEBER E ZARN J RUPPERT M ZELLER Y VESTWEBER D STAHEL R SAMMAR M ALTEVOGT P
Citation: S. Aigner et al., CD24, A MUCIN-TYPE GLYCOPROTEIN, IS A LIGAND FOR P-SELECTIN ON HUMAN TUMOR-CELLS, Blood, 89(9), 1997, pp. 3385-3395
INITIAL PROGNOSTIC FACTORS IN SMALL-CELL LUNG-CANCER PATIENTS PREDICTING QUALITY-OF-LIFE DURING CHEMOTHERAPY
Authors: BERNHARD J HURNY C BACCHI M JOSS RA CAVALLI F SENN HJ LEYVRAZ S STAHEL R LUDWIG C ALBERTO P
Citation: J. Bernhard et al., INITIAL PROGNOSTIC FACTORS IN SMALL-CELL LUNG-CANCER PATIENTS PREDICTING QUALITY-OF-LIFE DURING CHEMOTHERAPY, British Journal of Cancer, 74(10), 1996, pp. 1660-1667
EARLY VERSUS LATE ALTERNATING CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: JOSS RA BACCHI M HURNY C BERNHARD J CERNY T MARTINELLI G LEYVRAZ S SENN HJ STAHEL R SIEGENTHALER P LUDWIG C ALBERTO P
Citation: Ra. Joss et al., EARLY VERSUS LATE ALTERNATING CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Annals of oncology, 6(2), 1995, pp. 157-166
QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE
Authors: JOSS RA ALBERTO P HURNY C BACCHI M LEYVRAZ S THURLIMANN B CERNY T MARTINELLI G STAHEL R LUDWIG C
Citation: Ra. Joss et al., QUALITY VERSUS QUANTITY OF LIFE IN THE TREATMENT OF PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III COMPARISON OF WEEKLY CARBOPLATIN AND TENIPOSIDE VERSUS CISPLATIN, ADRIAMYCIN, ETOPOSIDE ALTERNATING WITH CYCLOPHOSPHAMIDE, METHOTREXATE, VINCRISTINE AND LOMUSTINE, Annals of oncology, 6(1), 1995, pp. 41-48
EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT
Authors: BUNN PA VANZANDWIJK N PASTORINO U AISNER J ALBERTO P ARRIAGADA R CARNEY D CORNIS R DITTRICH C GATZEMEIER U GINSBERG R GRECO FA HANSEN HH HARPER P HENRIKSSON R HUBER H KLENER P LECHEVALIER T LEWENSOHN R MURRAY N NIEDERLE N POSTMUS P ROSELL R SCAGLIOTTI G SCULIER JP SPLINTER T STAHEL R SYMANN M THATCHER N TONATO M TURRISI A
Citation: Pa. Bunn et al., EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT, European journal of cancer, 30A(5), 1994, pp. 710-713
WEEKLY CARBOPLATIN AND VM-26 FOR ELDERLY PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: MICHEL G LEYVRAZ S BAUER J AAPRO M STAHEL R ALBERTO P
Citation: G. Michel et al., WEEKLY CARBOPLATIN AND VM-26 FOR ELDERLY PATIENTS WITH SMALL-CELL LUNG-CANCER, Annals of oncology, 5(4), 1994, pp. 369-370
PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER
Authors: FELD R BORGES M GINER V GINSBERG R HARPER P KLASTERSKY J LACQUET L PAESMANS M PAYNE D ROSELL R SAUSE W SCULIER JP SHAW E SORENSEN JB SPLINTER T STAHEL R BUNN P
Citation: R. Feld et al., PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER, Lung cancer, 11, 1994, pp. 19-23
BIOLOGICAL BASIS OF COMBINED THERAPY
Authors: SOUHAMI RL BRODIN O DUCHESNE G GOLDIE J GREEN M KIES M MATTSON K MULSHINE J SAIJO N SAUNDERS M STAHEL R TANNOCK I
Citation: Rl. Souhami et al., BIOLOGICAL BASIS OF COMBINED THERAPY, Lung cancer, 10, 1994, pp. 190000003-190000005
DIFFUSE THYMIC HYPERPLASIA FOLLOWING CHEM OTHERAPY FOR NODULAR SCLEROSING HODGKINS-DISEASE
Authors: HERMANN R GREMINGER P DOMMANNSCHERRER C KRESTIN GP STAHEL R
Citation: R. Hermann et al., DIFFUSE THYMIC HYPERPLASIA FOLLOWING CHEM OTHERAPY FOR NODULAR SCLEROSING HODGKINS-DISEASE, Schweizerische medizinische Wochenschrift, 124(38), 1994, pp. 1666-1671
Risultati: 1-13 |